5-7 marzo
Vienna, Austria
Fragments 2017 – 6th RSC-BMCS Fragment-based Drug Discovery meeting
Abstract: P04 – Purinome targeted, fragment based lead discovery: identification of novel HSP90 inhibitors
Menu
5-7 marzo
Vienna, Austria
Fragments 2017 – 6th RSC-BMCS Fragment-based Drug Discovery meeting
Abstract: P04 – Purinome targeted, fragment based lead discovery: identification of novel HSP90 inhibitors
Nerviano Medical Sciences S.r.l.
Viale Luigi Pasteur 10
20014 Nerviano (MI)
Italy
Share Capital: € 1,200,000.00
fully paid-in
Company subject to the management and coordination of NMS Group S.p.A.